07:00 , Oct 24, 2016 |  BC Week In Review  |  Financial News

Biostar Pharmaceuticals completes direct public offering

Biostar Pharmaceuticals Inc. (NASDAQ:BSPM), Xianyang, China  Business: Pharmaceuticals  Date completed: 2016-10-18  Type: Direct public offering  Raised: $1.9 million  Shares: 425,000  Price: $4.50  Shares after offering: 2.6 million  Placement agent: FT Global Capital  Investor: Institutional investors ...
07:00 , Jul 13, 2015 |  BC Week In Review  |  Financial News

BioStar Ventures L.P. financial update

BioStar Ventures L.P. , Petoskey, Mich.   Business: Finance   Date announced: 2015-07-09   Note: BioStar Ventures has raised $68.8 million for its BioStar III fund. The firm plans to raise $100 million for the...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Financial News

Biostar Pharmaceuticals financial update

Biostar Pharmaceuticals filed a shelf registration covering the sale of up to $35 million of its securities. The company, which closed Friday at $2.41, has 12.3 million shares outstanding. Biostar Pharmaceuticals Inc. (NASDAQ:BSPM), Xianyang, China...
08:00 , Nov 18, 2013 |  BC Week In Review  |  Financial News

Biostar Pharmaceuticals financial update

Biostar received notice from NASDAQ that it regained compliance with the $1 minimum bid price requirement for continued listing. Biostar Pharmaceuticals Inc. (NASDAQ:BSPM), Xianyang, China   Business: Pharmaceuticals   Date announced: 11/13/13  ...
07:00 , Jun 24, 2013 |  BC Week In Review  |  Financial News

BioStar Ventures L.P. financial update

BioStar Ventures plans to raise $100 million for its third fund, according to an SEC filing. BioStar initially invests $250,000-$3 million in cardiovascular, orthopedic and neuroscience medical device companies primarily in the U.S. The firm...
00:48 , Jun 21, 2013 |  BC Extra  |  Financial News

BioStar Ventures seeking $100M for third fund

BioStar Ventures plans to raise $100 million for its third fund, according to an SEC filing. BioStar initially invests $250,000-$3 million in cardiovascular, orthopedic and neuroscience medical device companies primarily in the U.S. The firm...
07:00 , May 6, 2013 |  BC Week In Review  |  Company News

AltheRx board of directors update

AltheRx Pharmaceuticals , Exton, Pa.   Business: Autoimmune, Genitourinary   Appointed: Charles Becker, chairman of Becker Ventures, as chairman; Jeffery O'Donnell, a managing director of BioStar Ventures, as vice chairman; and Anthony Zook, formerly CEO...
08:00 , Dec 10, 2012 |  BC Week In Review  |  Financial News

Kona Medical financial update

Kona Medical raised an additional $10 million in equity and debt in a series C round, bringing the total raised to $40 million. Two undisclosed large-cap strategic investors joined existing investors Essex Woodlands; Domain Associates;...
07:00 , Jun 25, 2012 |  BC Week In Review  |  Company News

Biostar Pharmaceuticals, Fourth Military Medical University deal

Biostar signed a letter of intent with the university to jointly conduct Phase I through Phase III trials of the university's Viacom Pine II Cream to treat skin diseases, such as bacterial and fungal infections,...
07:00 , Jun 4, 2012 |  BC Week In Review  |  Financial News

Kona Medical completes venture financing

Kona Medical Inc. , Bellevue, Wash.   Business: Cardiovascular   Date completed: 5/30/12   Type: Venture financing   Raised: $30 million   Investors: Essex Woodlands Health Ventures; Domain Associates; Morgenthaler Ventures; BioStar Ventures  ...